{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:57:00Z","timestamp":1783000620620,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.msard.2022.104395","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T13:14:00Z","timestamp":1667481240000},"page":"104395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study"],"prefix":"10.1016","volume":"68","author":[{"given":"Giuseppina","family":"Miele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Abbadessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cavalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolama Alessandra","family":"Marfia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriana","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vercellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ponzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Lavorgna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-9720","authenticated-orcid":false,"given":"Simona","family":"Bonavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.msard.2022.104395_bib0001","doi-asserted-by":"crossref","first-page":"8163","DOI":"10.3390\/ijerph18158163","article-title":"CD19 cell count at baseline predicts B cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab","volume":"18","author":"Abbadessa","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.msard.2022.104395_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103740","article-title":"Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells","volume":"60","author":"Abbadessa","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2022.104395_bib0003","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio","year":"2014","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.msard.2022.104395_bib0004","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ejcn.2016.51","article-title":"Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis","volume":"70","author":"Brola","year":"2016","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.msard.2022.104395_bib0005","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s13311-021-01104-8","article-title":"Predictors of ocrelizumab effectiveness in patients with multiple sclerosis","volume":"18","author":"Cellerino","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"199","key":"10.1016\/j.msard.2022.104395_bib0006","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/ane.12431","article-title":"Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection","volume":"132","author":"Correale","year":"2015","journal-title":"Acta Neurol. Scand."},{"issue":"8","key":"10.1016\/j.msard.2022.104395_bib0007","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10072-018-3440-0","article-title":"Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod","volume":"39","author":"Ferre'","year":"2018","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.msard.2022.104395_bib0008","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jamaneurol.2015.2742","article-title":"Association of vitamin D levels with multiple sclerosis activity and progression in patients receiving interferon beta-1b","volume":"72","author":"Fitzgerald","year":"2015","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.msard.2022.104395_bib0009","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40265-017-0757-6","article-title":"Ocrelizumab: first global approval","volume":"77","author":"Frampton","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.msard.2022.104395_bib0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2016.03.011","article-title":"Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis","volume":"294","author":"Haas","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.msard.2022.104395_bib0011","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"OPERA I and OPERA II clinical investigators. ocrelizumab versus interferon beta- 1a in relapsing Multiple Sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.msard.2022.104395_bib0012","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1212\/WNL.0000000000008445","article-title":"Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon \u03b2-1a","volume":"93","author":"Hupperts","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.104395_bib0013","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.msard.2016.10.005","article-title":"Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab","volume":"10","author":"Laursen","year":"2016","journal-title":"Mult Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2022.104395_bib0014","article-title":"Inflammatory activity and vitamin D levels in an MS population treated with rituximab","volume":"5","author":"Linden","year":"2019","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"7","key":"10.1016\/j.msard.2022.104395_bib0015","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/biom10071032","article-title":"Low vitamin D states observed in U.S. marines and navy sailors with early multi-symptom illness","volume":"10","author":"Maloney","year":"2020","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.msard.2022.104395_bib0016","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage","volume":"8","author":"Mora","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.msard.2022.104395_bib0017","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1177\/1352458511425366","article-title":"Prevention and treatment of MS: studying the effects of vitamin D","volume":"17","author":"Munger","year":"2011","journal-title":"Mult. Scler."},{"issue":"23","key":"10.1016\/j.msard.2022.104395_bib0018","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.msard.2022.104395_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102350","article-title":"Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications","volume":"18","author":"Murdaca","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.msard.2022.104395_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156122","article-title":"Vitamin D status does not affect disability progression of patients with multiple sclerosis over three year follow-up","volume":"11","author":"Muris","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.msard.2022.104395_bib0021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/imm.12572","article-title":"Illuminating vitamin D effects on B cells\u2013the multiple sclerosis perspective","volume":"147","author":"Rolf","year":"2016","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.msard.2022.104395_bib0022","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1212\/NXI.0000000000000167","article-title":"Effect of vitamin D on MS activity by disease-modifying therapy class","volume":"2","author":"Rotstein","year":"2015","journal-title":"Neurology(R) Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.msard.2022.104395_bib0023","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3945\/ajcn.112.054502","article-title":"Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis","volume":"97","author":"Sachs","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.msard.2022.104395_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102186","article-title":"BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab","volume":"43","author":"Signoriello","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1-2","key":"10.1016\/j.msard.2022.104395_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2007.11.014","article-title":"Vitamin D as an immune modulator in multiple sclerosis, a review","volume":"194","author":"Smolders","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.msard.2022.104395_bib0026","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00415-020-09930-0","article-title":"Diagnosis and management of multiple sclerosis: MRI in clinical practice","volume":"267","author":"Tomassini","year":"2020","journal-title":"J. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822008999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822008999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:12:33Z","timestamp":1761901953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822008999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":26,"alternative-id":["S2211034822008999"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104395","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104395"}}